Medicare Enrolled
Dr. M Jawadi, M.D
Endocrinology · Springfield, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jawadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jawadi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jawadi
Dr. M Jawadi is an endocrinology specialist in Springfield, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jawadi performed 1,830 Medicare services across 688 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jawadi received a total of $18,587 from 59 pharmaceutical and/or device companies across 1288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jawadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in OH
$18,587 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,830
Medicare services
Top 16% in OH for endocrinology
688
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
491 | $60 | $85 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
430 | $84 | $141 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
248 | $59 | $99 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
243 | $121 | $198 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
172 | $89 | $135 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
111 | $25 | $55 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $106 | $185 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
48 | $100 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $134 | $204 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
13 | $9 | $29 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,587
Total received (2018-2024)
Avg $2,655/year across 7 years
Top 17% in OH for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,288
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,587 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,236
2023
$2,451
2022
$2,822
2021
$2,975
2020
$2,120
2019
$2,570
2018
$2,412
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$373
Dexcom, Inc.
$345
Amgen Inc.
$302
Lilly USA, LLC
$291
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
Novo Nordisk Inc
$195
Xeris Pharmaceuticals, Inc.
$194
CeQur Corporation
$185
Abbott Laboratories
$183
Tandem Diabetes Care, Inc.
$179
BETA BIONICS, INC.
$175
Corcept Therapeutics
$140
Esperion Therapeutics, Inc.
$90
Amneal Pharmaceuticals LLC
$77
Insulet Corporation
$60
Medtronic, Inc.
$58
Radius Health, Inc.
$41
ABBVIE INC.
$38
Nevro Corp.
$28
Eisai Inc.
$24
Astellas Pharma US Inc
$19
Top 3 companies account for 31.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,781
Corcept Therapeutics
$1,647
AstraZeneca Pharmaceuticals LP
$1,478
Lilly USA, LLC
$1,473
Abbott Laboratories
$1,110
Amgen Inc.
$1,004
SANOFI-AVENTIS U.S. LLC
$861
Amarin Pharma Inc.
$825
Dexcom, Inc.
$804
Boehringer Ingelheim Pharmaceuticals, Inc.
$673
Bayer Healthcare Pharmaceuticals Inc.
$652
Merck Sharp & Dohme Corporation
$571
Xeris Pharmaceuticals, Inc.
$425
Radius Health, Inc.
$393
Insulet Corporation
$359
ABBVIE INC.
$296
Zealand Pharma US, Inc.
$290
Bayer HealthCare Pharmaceuticals Inc.
$255
AbbVie Inc.
$253
Tandem Diabetes Care, Inc.
$249
CeQur Corporation
$215
Amneal Pharmaceuticals LLC
$207
Shire North American Group Inc
$206
Kowa Pharmaceuticals America, Inc.
$195
Esperion Therapeutics, Inc.
$190
Merck Sharp & Dohme LLC
$179
BETA BIONICS, INC.
$175
Janssen Pharmaceuticals, Inc
$167
AbbVie, Inc.
$141
Medtronic, Inc.
$134
Valeritas, Inc.
$130
DEXCOM, INC.
$123
LifeScan, Inc.
$102
Eisai Inc.
$81
Novartis Pharmaceuticals Corporation
$80
Medtronic MiniMed, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$63
PFIZER INC.
$61
EISAI INC.
$57
Evoke Pharma, Inc.
$56
Clarus Therapeutics Inc.
$55
MannKind Corporation
$53
Antares Pharma, Inc.
$50
Gemini Laboratories, LLC
$43
Nevro Corp.
$43
Acerus Pharmaceuticals Corporation
$41
Alexion Pharmaceuticals, Inc.
$40
Becton, Dickinson and Company
$37
Horizon Therapeutics plc
$31
GRT US Holding, Inc.
$20
Sun Pharmaceutical Industries Inc.
$19
Astellas Pharma US Inc
$19
Ascendis Pharma Inc
$18
Aegerion Pharmaceuticals, Inc.
$17
Kyowa Kirin, Inc.
$14
Amryt Pharma Holdings Ltd
$14
Renalytix AI, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano · BREZTRI · Belviq · CHANTIX · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Corlanor · Creon · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GIMOTI · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN U · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · KAPSPARGO · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Lenvima · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Natesto · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · Prolia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · SOMAVERT · STEGLATRO · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · Senza · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRINTELLIX · TRULICITY · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
12
Per 100K population
8.9
County median income
$60,846
Nearest hospital
SPRINGFIELD REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jawadi is a clinical cardiology specialist, with above-average Medicare volume (top 16% in OH), with low-engagement industry engagement in the top 17% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jawadi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Jawadi performed 491 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jawadi receive payments from pharmaceutical companies?
Yes. Dr. Jawadi received a total of $18,587 from 59 companies across 1,288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jawadi's costs compare to other endocrinologists in Springfield?
Dr. Jawadi's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jawadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Springfield
Browse endocrinologists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in OH
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in OH
Which OH endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology